Couchbase Insider Sold Shares Worth $412,671, According to a Recent SEC Filing-April 2024-www.financetom.com

Couchbase Insider Sold Shares Worth $412,671, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Couchbase Insider Sold Shares Worth $412,671, According to a Recent SEC Filing

Mar 8, 2024 3:28 PM

06:02 PM EST, 03/08/2024 (MT Newswires) -- Huw Owen, Senior Vice President & Chief Revenue Officer, on March 06, 2024, sold 13,605 shares in Couchbase ( BASE ) for $412,671. Following the Form 4 filing with the SEC, Owen has control over a total of 467,967 shares of the company, with 467,967 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1845022/000193179924000010/xslF345X03/wk-form4_1709938580.xml

Price: 28.32, Change: -0.01, Percent Change: -0.04

Previous page： Lufthansa extends flight cancellations from Frankfurt to Tehran on security concerns Next page： PACS Group Prices Upsized $450 Million Initial Public Offering

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Lufthansa extends flight cancellations from Frankfurt to Tehran on security concerns

Apr 11, 2024

FRANKFURT, April 11 (Reuters) - German airline Lufthansa has extended the cancellation of daily flights from Frankfurt to Tehran due to security concerns until April 13, a spokesperson said on Thursday. The decision was taken last weekend to avoid a situation where the airline's crew had to stay overnight in Tehran, the spokesperson added. ...

PACS Group Prices Upsized $450 Million Initial Public Offering

Apr 11, 2024

03:41 AM EDT, 04/11/2024 (MT Newswires) -- PACS Group ( PACS ) said late Wednesday it priced its initial public offering of approximately 21.4 million common shares at $21 per share for gross proceeds of about $450 million. Certain selling stockholders have granted the underwriters a 30-day option to purchase up to 3.2 million additional shares. The company said it...

Gerresheimer expects sales boost from burgeoning obesity drugs sector

Apr 11, 2024

April 11 (Reuters) - German packaging and medical equipment maker Gerresheimer expects diabetes and diet drugs to contribute 350 million euros ($376 million) of annual revenue by the 2026/27 financial year, CFO Bernd Metzner told Reuters after the company reported first-quarter results on Thursday. Obesity drugs such as Novo Nordisk's Wegovy and Eli Lilly's ( LLY ) Zepbound are administered...

AstraZeneca unveils dividend hike ahead of CEO pay vote at AGM

Apr 11, 2024

(Reuters) -AstraZeneca said on Thursday it intends to increase annual dividend for 2024 by 7% to $3.10 per share, betting on strong performance and cash generation on the back of its blockbuster drugs and several recent acquisitions. The announcement comes ahead of its annual general meeting later in the day, where investors are preparing to vote on a policy that...